Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential-Reference-Cited by-同舟云学术

Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential

Published:2020-11 Issue:10263 Volume:396 Page:1611-1613
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Krause Philip R,Fleming Thomas R,Ellenberg Susan S,Henao-Restrepo Ana Maria,Krause PR,Fleming T,Alejandria MM,Bhargava B,Ellenberg S,Garcia PJ,Halloran E,Henao-Restrepo AM,Longini I,Miranda Montoya MC,Roses M,Sommerfelt H

Publisher

Elsevier BV

Subject

General Medicine

Reference9 articles.

1. COVID vaccine trials should seek worthwhile efficacy;Krause;Lancet,2020

2. Data monitoring committees in clinical trials: a practical perspective;Ellenberg,2019

3. Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial;Business Wire,2020

4. Moderna CEO eyes December for COVID vaccine;Loftus;MarketWatch,2020

5. Data Monitoring Committees: promoting best practices to address emerging challenges;Fleming;Clin Trials,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inferring vaccine efficacy and mode of action from human challenge studies;2023-09-25

2. Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection;Frontiers in Immunology;2021-09-16

3. Towards reliable and transparent vaccine phase III trials with smart contracts;2021 IEEE International Conference on Omni-Layer Intelligent Systems (COINS);2021-08-23

4. The Economic, Climate Change and Public Health Edges of the Geopolitics of COVID-19: An Exploratory Bibliometric Analysis;Biotechnology to Combat COVID-19 [Working Title];2021-03-23

5. How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is Available;Clinical Infectious Diseases;2021-02-26